BG105430A - Compositions and methods for the supply of powder active substance in the lungs - Google Patents

Compositions and methods for the supply of powder active substance in the lungs

Info

Publication number
BG105430A
BG105430A BG105430A BG10543001A BG105430A BG 105430 A BG105430 A BG 105430A BG 105430 A BG105430 A BG 105430A BG 10543001 A BG10543001 A BG 10543001A BG 105430 A BG105430 A BG 105430A
Authority
BG
Bulgaria
Prior art keywords
lungs
compositions
supply
methods
active substance
Prior art date
Application number
BG105430A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Clark
Mei-Chang Kuo
Cecily Lalor
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Publication of BG105430A publication Critical patent/BG105430A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
BG105430A 1998-09-14 2001-04-10 Compositions and methods for the supply of powder active substance in the lungs BG105430A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (fr) 1998-09-14 1999-09-13 Administration par voie pulmonaire d'un agent actif sous forme de poudre seche

Publications (1)

Publication Number Publication Date
BG105430A true BG105430A (en) 2001-12-29

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105430A BG105430A (en) 1998-09-14 2001-04-10 Compositions and methods for the supply of powder active substance in the lungs

Country Status (44)

Country Link
EP (1) EP1117442A1 (fr)
JP (1) JP2002524535A (fr)
KR (1) KR20010075063A (fr)
CN (1) CN1317977A (fr)
AP (1) AP1374A (fr)
AR (1) AR022090A1 (fr)
AU (1) AU753014B2 (fr)
BG (1) BG105430A (fr)
BR (1) BR9913722A (fr)
CA (1) CA2343920A1 (fr)
CO (1) CO5130023A1 (fr)
CZ (1) CZ2001829A3 (fr)
DZ (1) DZ2892A1 (fr)
EA (1) EA003476B1 (fr)
EE (1) EE200100151A (fr)
GE (1) GEP20043257B (fr)
GT (1) GT199900156A (fr)
HK (1) HK1042231A1 (fr)
HN (1) HN1999000159A (fr)
HR (1) HRP20010189A2 (fr)
HU (1) HUP0103837A3 (fr)
ID (1) ID28845A (fr)
IL (2) IL141562A0 (fr)
IS (1) IS5878A (fr)
LT (1) LT4897B (fr)
LV (1) LV12658B (fr)
MA (1) MA25590A1 (fr)
MY (1) MY129282A (fr)
NO (1) NO20011251L (fr)
NZ (1) NZ510168A (fr)
OA (1) OA11781A (fr)
PA (1) PA8481901A1 (fr)
PE (1) PE20001061A1 (fr)
PL (1) PL195574B1 (fr)
SA (1) SA99200718B1 (fr)
SK (1) SK3442001A3 (fr)
TN (1) TNSN99173A1 (fr)
TR (1) TR200101182T2 (fr)
TW (1) TWI226248B (fr)
UA (1) UA76085C2 (fr)
UY (1) UY25711A1 (fr)
WO (1) WO2000015262A1 (fr)
YU (1) YU24201A (fr)
ZA (1) ZA200101995B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630121B1 (en) 1999-06-09 2003-10-07 The Regents Of The University Of Colorado Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
EP1392262A1 (fr) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
PL373780A1 (en) 2002-02-25 2005-09-19 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
JP2006513139A (ja) * 2002-07-03 2006-04-20 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド 治療薬の全身性送達のための中央部気道投与
WO2004060352A1 (fr) * 2002-12-19 2004-07-22 Pharmacia Corporation Intermediaire pour formulation a caractere non-hygroscopique acceptable comprenant un bouchon hydroscopique
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
LT2708225T (lt) 2004-04-23 2019-04-10 Cydex Pharmaceuticals, Inc. Dpi kompozicija, turinti sulfoalkilo eterio ciklodekstrino
UA95903C2 (ru) 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Транс-каротиноиды, их синтез, лекарственная форма и применение
KR20070110418A (ko) * 2005-03-09 2007-11-16 오노 야꾸힝 고교 가부시키가이샤 입자 및 그 입자를 함유하는 제제
ES2526903T3 (es) 2005-10-26 2015-01-16 Cydex Pharmaceuticals, Inc. Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
CN101541311B (zh) * 2006-10-25 2013-01-23 大日本住友制药株式会社 不易结块的颗粒制剂
EP1925295A1 (fr) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Formule de poudre stable contenant un nouveau anticholinergique
JP2010524855A (ja) 2007-04-13 2010-07-22 ディフュージョン・ファーマシューティカルズ・エルエルシー 末梢血管疾患の前処置としての、及びその処置における双極性トランスカロテノイドの使用
BRPI0818119A2 (pt) 2007-10-31 2015-08-04 Diffusion Pharmaceuticals Llc Uma nova classe de produtos terapêuticos que melhoram difusão de molécula pequena
ES2661215T3 (es) * 2009-05-20 2018-03-28 Aeras Composiciones víricas; inmunógenas; secadas por pulverización; estables
EP2445339B1 (fr) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Composé améliorant la diffusion et son utilisation avec un thrombolytique
CN105287473A (zh) 2010-06-02 2016-02-03 扩散药品有限公司 包含双极性反式类胡萝卜素的组合物及其应用
US9682096B2 (en) 2012-05-02 2017-06-20 Janssen R & D Ireland Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
MX2017005692A (es) 2014-10-31 2017-08-07 Glaxosmithkline Ip Dev Ltd Formulacion en polvo.
KR20230014850A (ko) 2016-03-24 2023-01-30 디퓨젼 파마슈티컬즈 엘엘씨 암을 치료하기 위한, 화학 요법 및 방사선 요법과의 양극성 트랜스 카로티노이드의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
WO1993025198A1 (fr) * 1992-06-12 1993-12-23 Teijin Limited Poudre ultra-fine pour inhalation et production de cette poudre
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
EP0954282B1 (fr) * 1997-01-16 2005-01-19 Massachusetts Institute Of Technology Preparation de particules pour inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
MY129282A (en) 2007-03-30
PA8481901A1 (es) 2002-04-25
AP1374A (en) 2005-02-28
OA11781A (en) 2005-07-26
IS5878A (is) 2001-03-05
CA2343920A1 (fr) 2000-03-23
NZ510168A (en) 2003-09-26
PE20001061A1 (es) 2000-10-08
HUP0103837A2 (hu) 2002-05-29
EP1117442A1 (fr) 2001-07-25
JP2002524535A (ja) 2002-08-06
GT199900156A (es) 2001-03-07
TWI226248B (en) 2005-01-11
PL195574B1 (pl) 2007-10-31
CO5130023A1 (es) 2002-02-27
LV12658B (lv) 2001-09-20
IL141562A0 (en) 2002-03-10
AU6039799A (en) 2000-04-03
ZA200101995B (en) 2002-03-11
ID28845A (id) 2001-07-05
TR200101182T2 (tr) 2001-09-21
GEP20043257B (en) 2004-06-25
TNSN99173A1 (fr) 2005-11-10
AU753014B2 (en) 2002-10-03
SK3442001A3 (en) 2001-11-06
CZ2001829A3 (cs) 2001-09-12
IL141562A (en) 2007-07-24
EA200100300A1 (ru) 2001-10-22
KR20010075063A (ko) 2001-08-09
EA003476B1 (ru) 2003-06-26
LT2001021A (en) 2001-11-26
LV12658A (lv) 2001-05-20
BR9913722A (pt) 2001-05-29
HRP20010189A2 (en) 2005-04-30
DZ2892A1 (fr) 2003-12-15
EE200100151A (et) 2002-06-17
MA25590A1 (fr) 2002-12-31
UY25711A1 (es) 1999-11-17
NO20011251D0 (no) 2001-03-13
NO20011251L (no) 2001-04-17
HK1042231A1 (zh) 2002-08-09
AR022090A1 (es) 2002-09-04
SA99200718B1 (ar) 2006-11-04
YU24201A (sh) 2003-08-29
HUP0103837A3 (en) 2002-11-28
UA76085C2 (en) 2006-07-17
AP2001002093A0 (en) 2001-03-31
HN1999000159A (es) 1999-11-11
LT4897B (lt) 2002-02-25
WO2000015262A1 (fr) 2000-03-23
PL346768A1 (en) 2002-02-25
CN1317977A (zh) 2001-10-17

Similar Documents

Publication Publication Date Title
BG105430A (en) Compositions and methods for the supply of powder active substance in the lungs
IS5108A (is) Ný lyfjablanda til innöndunar með eðlisþyngd í lausu sem er frá 0,28 til 0,38 g/ml, aðferð við að framleiða lyfjablönduna og notkun hennar
NZ511527A (en) Dry powder for inhalation
SE8902377D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
HU9201521D0 (en) Stimulating unit containing nicotine
EE04794B1 (et) Näts, meetod nätsu kompositsiooni valmistamiseks ja naturaalse taimse komponendi kasutamine nätsu kattes
WO1996017587A3 (fr) Preparations pour soins bucco-dentaires contenant des composes stanniques stabilises
PT877602E (pt) Processo para o fabrico de composicoes de surfactantes pulmonares em po
IT1247945B (it) Agente avente attivita' batteriostatica e battericida
EP0792653A3 (fr) Matériau polysaccharide solide et son utilisation comme pansement pour blessure
HUT77000A (hu) Szubsztituált pirazinszármazékok, előállításuk és alkalmazásuk, valamint hatóanyagként ezeket a vegyületeket tartalmazó herbicid készítmények
ZA973751B (en) Pesticides comprising benzophenanthridine alkaloids.
EP0212837A3 (fr) Agent désodorisant
TW325393B (en) Methods of making a dry, flowable powder of acifluorfen and a composition prepared therefrom
EP0286601A3 (fr) Composition déodorante en poudre pour chaussures, en particulier pour chaussures de sport
EP0337212A3 (fr) Gels de silice pour lutter contre les insectes
WO2005039288A3 (fr) Composition insecticide a activite synergique renforcee
SE8300495D0 (sv) Improvements in or relating to nasal pharmaceutical compositions
JPS5742617A (en) Flexible cataplasma
JPS5699766A (en) Preparation of modified starch
EP0010515A3 (en) (n-methylcarbamoyl-phenoxy)-(n'.n".n"-trialkyl urea)-n.n'-sulfide derivatives, process for their preparation, compositions containing these derivatives as active components and their use in combating insects; (n-methyl-carbamoylhalogenide)-(n'.n".n'"-trialkyl urea)-n.n' sulfides and process for their preparation
AR224932A1 (es) Composiciones herbicidas que contienen como agente activo 3-amino-triazol clorhidrato,solo o en mezcla con tiocianatos solubles y procedimientos para prepararlos
MX9707902A (es) Composiciones de zinc que conservan todo el aroma para uso oral que incorpora cobre.
ES8802560A1 (es) Un metodo para la preparacion de derivados estables efervescentes de acido acetilsalicilico con propiedades antihistaminicas.
RU97112112A (ru) Способ приготовления родентицидных средств и родентицидное средство